Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001354488-14-002936
Filing Date
2014-05-22
Accepted
2014-05-22 16:47:32
Documents
8

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT sbfm_s1.htm S-1 2443960
2 OPINION sbfm_ex52.htm EX-5.2 8953
3 CONSENT sbfm_ex232.htm EX-23.2 3318
4 CONSENT sbfm_ex233.htm EX-23.3 7061
5 img001.jpg GRAPHIC 17227
6 img002.jpg GRAPHIC 21300
7 img003.jpg GRAPHIC 15049
8 img004.jpg GRAPHIC 12653
  Complete submission text file 0001354488-14-002936.txt   2556223
Mailing Address 469 JEAN-TALON WEST 3RD FLOOR MONTREAL A8 H3N 1R4
Business Address 469 JEAN-TALON WEST 3RD FLOOR MONTREAL A8 H3N 1R4 514-764-9698
Sunshine Biopharma, Inc (Filer) CIK: 0001402328 (see all company filings)

EIN.: 205566275 | State of Incorp.: CO | Fiscal Year End: 1231
Type: S-1 | Act: 33 | File No.: 333-196191 | Film No.: 14864280
SIC: 8742 Services-Management Consulting Services